Paid Clinical Trials in Albuquerque, NM
As of August 2026, 322 paid clinical trials are recruiting in Albuquerque, New Mexico. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Albuquerque offers studies at sites including University of New Mexico Cancer Center for conditions such as Breast Cancer, Ovarian Cancer, Acute Myeloid Leukemia, Endometrial Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Albuquerque
Trials by drug in Albuquerque
Filter results
Newly added in Albuquerque
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
303 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Top Research Study Locations in Albuquerque
Researchers run research studies in Albuquerque, NM at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of New Mexico Cancer Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8 | 80 |
| University of New Mexico | Infant, Small for Gestational Age, Chronic Pain, Diabetes | 45 |
| Presbyterian Kaseman Hospital | Anatomic Stage II Breast Cancer AJCC v8, Melanoma, Metastatic Breast Cancer | 14 |
| University of New Mexico Health Sciences Center | Interstitial Lung Disease, AVM, Arteriovenous Malformations | 13 |
| University of New Mexico Comprehensive Cancer Center | Anemia, Cancer, Cancer Risk | 12 |
| Presbyterian Hospital | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Adrenal Gland Pheochromocytoma | 9 |
| University of New Mexico Hospital | Hidradenitis Suppurativa (HS), Lumbar Spinal Stenosis, Postoperative Physical Functioning | 7 |
| Lovelace Medical Center-Saint Joseph Square | Malignant Solid Neoplasm, Melanoma, Acute Lymphoblastic Leukemia | 6 |
| Lovelace Women's Hospital | Malignant Solid Neoplasm, Melanoma, Acute Lymphoblastic Leukemia | 6 |
| Albuquerque Clinical Trials, Inc. | Obesity, Overweight, Acute Gout Flare | 5 |
| New Mexico Heart Institute | Atrial Fibrillation, Cardiovascular Diseases, Heart Diseases | 4 |
| New Mexico VA Health Care System, Albuquerque, NM | Atherosclerosis, Bipolar Disorder, Chronic Kidney Disease (CKD) Stage 5 | 4 |
| The Mind Research Network | Aging Disorder, Alcohol Use Disorder, Criminal Behavior | 4 |
| Albuquerque Clinical Trials | Acute Migraine, Migraine, Type 2 Diabetes | 3 |
| New Mexico Oncology Hematology Consultants | Cancer, Malignant Neoplasm, Metastatic Castration-Resistant Prostate Cancer | 3 |
| The University of New Mexico Comprehensive Cancer Center | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer | 3 |
| University of New Mexico Health Science Center | Chronic Kidney Diseases, Cognitive Change, Depression | 3 |
| Vision Research Center Eye Associates of New Mexico | Diabetic Retinopathy, DR, Neovascular Age-Related Macular Degeneration (nAMD), Neovascular Age-related Macular Degeneration | 3 |
| New Mexico Oncology Hematology Consultants Ltd. | Metastatic Castration-resistant Prostate Cancer, Triple Negative Breast Neoplasms, Triple-Negative Breast Cancer | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Albuquerque Rehabilitation and Rheumatology | Arthritis, Psoriatic | 2 |
| Eye Associates of New Mexico, Vision Research Center | Macular Edema Secondary to Inflammation | 2 |
| IMA Clinical Research | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Major Depressive Disorder | 2 |
| IMA Clinical Research - Albuquerque | Alzheimers Disease | 2 |
| Lovelace Health System | Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Pulmonary Embolism | 2 |
Active & Upcoming Studies in Albuquerque (2026)
Recruiting trials in Albuquerque grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (121 active studies)
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · Phase 2, Phase 3 · Eikon Therapeutics
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) · Phase 3 · AstraZeneca
Cardiovascular (25 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Diabetes & metabolic (22 active studies)
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
Neurology & pain (19 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Mental health & behavior (8 active studies)
- Enhancing Veteran-Clinical Collaboration in VA PRRCs · VA Office of Research and Development
- Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder · Phase 1 · University of New Mexico
Eye & vision (8 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Pediatric (5 active studies)
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome · HELP for NOWS Consortium
- Neonatal Platelet Transfusion Threshold Trial · NICHD Neonatal Research Network
Vaccines (3 active studies)
- Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation · Phase 2 · University of New Mexico
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose · Phase 3 · Pfizer
Common conditions studied in Albuquerque
- Breast Cancer (8 active studies)
- Ovarian Cancer (8 active studies)
- Acute Myeloid Leukemia (7 active studies)
- Endometrial Cancer (7 active studies)
- Malignant Solid Neoplasm (7 active studies)
- Obesity (6 active studies)
Leading research sponsors in Albuquerque
- National Cancer Institute (NCI)
- University of New Mexico
- NRG Oncology
- AstraZeneca
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Albuquerque?
There are approximately 322 recruiting clinical trials in Albuquerque, New Mexico listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Albuquerque pay participants?
Most recruiting trials in Albuquerque compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Albuquerque?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Albuquerque?
The most common conditions under active study in Albuquerque include Breast Cancer (8), Ovarian Cancer (8), Acute Myeloid Leukemia (7), Endometrial Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Albuquerque?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Albuquerque on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Albuquerque?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Albuquerque?
Recruiting research sites in Albuquerque include University of New Mexico Cancer Center, University of New Mexico, Presbyterian Kaseman Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Albuquerque right now?
The largest active categories in Albuquerque are Cancer & tumors (121), Cardiovascular (25), Diabetes & metabolic (22). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.